SPX -0.58% VIX 4.38%
WAR OF WILL WINS 144TH PREAKNESS IN RACE THAT INCLUDED RIDERLESS HORSE
MICHIGAN GOP CONGRESSMAN SEEN AS FIRST OF PARTY TO SAY TRUMP ACTS IMPEACHABLE
AOC STANDS WITH BUFFETT: CEO NET WORTH SHOULD TAKE A HIT IF BAILOUT GIVEN
JOE BIDEN PITCHES HIMSELF AS A UNITER EVEN AS HE TEARS INTO TRUMP
HERE'S THE STOCK PLAY BOOSTED BY 'GAME OF THRONES' BANDWIDTH HOGS
THE TARIFF TIFF AND A FED RETHINK ARE JUST TWO AREAS OF STOCK-MARKET ANGST
ECONOMIC PREVIEW: CONSUMER SPENDING SLOWS, INVESTMENT HURT BY CHINA TRADE WAR
STRATEGIST: A NUMBER OF INDICATORS SUGGEST THE STOCK MARKET COULD EXTEND GAINS
AUSTRALIAS RULING CONSERVATIVE COALITION APPEARS HEADED TO A SURPRISE WIN
U.S. STOCKS END LOWER FOR DAY AND WEEK ON U.S.-CHINA TRADE UNCERTAINTY
Sun, May 19 8:56am

Health Care Sector Stocks 0

These Health Care Sector Stocks are listed on the Nasdaq or NYSE exchange.

View key information like the 1 year chart, stock price, market capitalization, earnings date, earnings per share, price to earnings ratio, dividend yield and ex-dividend date.

Click on the column headings to sort the data.



Screener
Min must be less than the Max.
Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Agilent Technologies Inc [A]
$69.11 0.19 (0.27%)

A Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 22.00 Billion
A Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading healthcare firm. Today, Agilent's measurement technologies serve a broad base of customers within three operating segments: life science and applied equipment (49% of sales), cross lab (which includes consumables and services at 34%), and diagnostics and genomics (17%). The United States and Europe account for 34% and 27% of revenue, respectively, with China and Japan accounting for the majority of remaining sales. Agilent is headquartered in California.


Visit Website

A Earnings

EPS 0.57 P/E Ratio 21.41
Previous Earnings Wed, Feb 20, 2019
Latest Earnings Tue, May 14, 2019 (5 days ago)

A Dividend

Yield 0.95% / $0.66
Ex-Date Mon, Apr 1, 2019 (48 days ago)
Pay Date Wed, Apr 24, 2019
History 29 Payments (Quarterly)

A Charts

$61.13
52 Week Range
$82.00
Oct 24, 2018
Mar 21, 2019

69.11 22.00 21.41 0.95 A NYSE -0.27 5.21 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=A&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=A&exchange=NYSE&chart=1

AbbVie Inc [ABBV]
$79.46 0.04 (0.05%)

ABBV Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 119.02 Billion
ABBV Description

AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.


Visit Website

ABBV Earnings

EPS 1.65 P/E Ratio 22.14
Previous Earnings Fri, Jan 25, 2019
Latest Earnings Thu, Apr 25, 2019 (24 days ago)

ABBV Dividend

Yield 5.39% / $4.28
Ex-Date Fri, Apr 12, 2019 (37 days ago)
Pay Date Wed, May 15, 2019
History 26 Payments (Quarterly)

ABBV Charts

$76.87
52 Week Range
$106.23
May 13, 2019
May 21, 2018

79.46 119.02 22.14 5.39 ABBV NYSE -0.05 -10.95 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABBV&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABBV&exchange=NYSE&chart=1

AmerisourceBergen Corp [ABC]
$77.73 0.14 (0.18%)

ABC Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 16.36 Billion
ABC Description

AmerisourceBergen is a leading global third-party logistics provider engaged in wholesale pharmaceutical sourcing and distribution of specialty, brand-name, and generic pharmaceuticals and related services to acute-care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, dialysis clinics, and other healthcare customers. By acquiring smaller companies, management has attained the ability to compound sterile preparations, distribute veterinary pharmaceuticals and vaccines, transport biopharmaceuticals, and provide inventory and reimbursement consulting services to providers.


Visit Website

ABC Earnings

EPS 0.13 P/E Ratio 13.91
Previous Earnings Thu, Jan 31, 2019
Latest Earnings Thu, May 2, 2019 (17 days ago)

ABC Dividend

Yield 2.06% / $1.60
Ex-Date Fri, May 17, 2019 (2 days ago)
Pay Date Mon, Jun 3, 2019
History 71 Payments (Quarterly)

ABC Charts

$70.76
52 Week Range
$94.85
Dec 24, 2018
Jun 15, 2018

77.73 16.36 13.91 2.06 ABC NYSE 0.18 4.41 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABC&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABC&exchange=NYSE&chart=1

Abbott Laboratories [ABT]
$75.97 0.63 (0.82%)

ABT Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 136.12 Billion
ABT Description

Abbott manufactures and markets medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and molecular and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.


Visit Website

ABT Earnings

EPS 0.38 P/E Ratio 59.16
Previous Earnings Wed, Jan 23, 2019
Latest Earnings Wed, Apr 17, 2019 (32 days ago)

ABT Dividend

Yield 1.68% / $1.28
Ex-Date Fri, Apr 12, 2019 (37 days ago)
Pay Date Wed, May 15, 2019
History 134 Payments (Quarterly)

ABT Charts

$60.49
52 Week Range
$80.06
Jun 27, 2018
Mar 21, 2019

75.97 136.12 59.16 1.68 ABT NYSE -0.82 9.31 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABT&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABT&exchange=NYSE&chart=1

Aetna Inc [AET]
$213.44 0.74 (0.35%)

AET Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 69.88 Billion
AET Description

Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.


Visit Website

AET Earnings

EPS 3.05 P/E Ratio 19.11
Previous Earnings --
Latest Earnings Tue, Oct 30, 2018 (201 days ago)

AET Dividend

Yield 0.94% / $2.00
Ex-Date Tue, Oct 23, 2018 (208 days ago)
Pay Date Thu, Nov 1, 2018
History 20 Payments (Quarterly)

AET Charts

$175.65
52 Week Range
$213.44
Jun 5, 2018
Nov 29, 2018

213.44 69.88 19.11 0.94 AET NYSE 0.35 1005.91 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AET&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AET&exchange=NYSE&chart=1

Allergan PLC [AGN]
$140.20 0.16 (0.11%)

AGN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 46.04 Billion
AGN Description

Allergan is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. In 2016, Allergan sold its generics and distribution segments to Teva.


Visit Website

AGN Earnings

EPS -7.25 P/E Ratio 0.00
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Tue, May 7, 2019 (12 days ago)

AGN Dividend

Yield 2.11% / $2.96
Ex-Date Mon, May 13, 2019 (6 days ago)
Pay Date Fri, Jun 14, 2019
History 10 Payments (Quarterly)

AGN Charts

$129.82
52 Week Range
$193.46
Dec 24, 2018
Oct 3, 2018

140.20 46.04 0.00 2.11 AGN NYSE 0.11 3.18 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AGN&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AGN&exchange=NYSE&chart=1

Alexion Pharmaceuticals Inc [ALXN]
$130.90 0.50 (0.38%)

ALXN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 29.46 Billion
ALXN Description

Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and generalized myasthenia gravis. Next-generation Ultomiris was recently approved in paroxysmal nocturnal hemoglobinuria. Strensiq and Kanuma target other ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need and complement-mediated disorders.


Visit Website

ALXN Earnings

EPS 2.63 P/E Ratio 392.83
Previous Earnings Mon, Feb 4, 2019
Latest Earnings Thu, Apr 25, 2019 (24 days ago)

ALXN Dividend

Yield --
Ex-Date --
Pay Date --
History --

ALXN Charts

$93.94
52 Week Range
$141.30
Dec 24, 2018
Apr 10, 2019

130.90 29.46 392.83 0.00 ALXN NASDAQ -0.38 33.50 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ALXN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ALXN&exchange=NASDAQ&chart=1

Amgen Inc [AMGN]
$169.91 0.01 (0.01%)

AMGN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 103.64 Billion
AMGN Description

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).


Visit Website

AMGN Earnings

EPS 3.20 P/E Ratio 15.15
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Tue, Apr 30, 2019 (19 days ago)

AMGN Dividend

Yield 3.41% / $5.80
Ex-Date Thu, May 16, 2019 (3 days ago)
Pay Date Fri, Jun 7, 2019
History 32 Payments (Quarterly)

AMGN Charts

$167.60
52 Week Range
$208.89
May 13, 2019
Sep 27, 2018

169.91 103.64 15.15 3.41 AMGN NASDAQ -0.01 -11.46 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AMGN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AMGN&exchange=NASDAQ&chart=1

Anthem Inc [ANTM]
$265.07 1.25 (0.47%)

ANTM Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 66.52 Billion
ANTM Description

Anthem is one of the largest private health insurance organizations nationwide, providing medical benefits to over 40 million members. The company offers employer-sponsored, individual, and government-backed coverage plans. Anthem differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states.


Visit Website

ANTM Earnings

EPS 6.03 P/E Ratio 18.53
Previous Earnings Wed, Jan 30, 2019
Latest Earnings Wed, Apr 24, 2019 (25 days ago)

ANTM Dividend

Yield 1.21% / $3.20
Ex-Date Fri, Jun 7, 2019 (In 19 days)
Pay Date Tue, Jun 25, 2019
History 34 Payments (Quarterly)

ANTM Charts

$221.42
52 Week Range
$317.42
May 31, 2018
Feb 26, 2019

265.07 66.52 18.53 1.21 ANTM NYSE 0.47 3.94 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ANTM&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ANTM&exchange=NYSE&chart=1

Baxter International Inc [BAX]
$75.98 0.92 (1.20%)

BAX Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 39.23 Billion
BAX Description

Baxter manufactures medical products across seven major reported business segments. The renal segment (33% of 2018 sales) includes peritoneal dialysis and hemodialysis products for chronically ill patients while its acute therapies segment (5%) offers kidney or other organ support tools in intensive care situations. The medication delivery segment (24% of sales) sells IV pumps, administrative sets, and solutions while its nutrition segment (8% of sales) offers parenteral nutrition therapies. The pharmaceuticals segments (19% of sales) offers injectable drugs, anesthetic gases, and compounding services. The advanced surgery segment (7% of sales) provides hemostastic products and biosurgical sealants. Contract manufacturing rounds out the remaining 5% of sales.


Visit Website

BAX Earnings

EPS 0.68 P/E Ratio 26.63
Previous Earnings Thu, Jan 31, 2019
Latest Earnings Thu, Apr 25, 2019 (24 days ago)

BAX Dividend

Yield 1.16% / $0.88
Ex-Date Thu, Jun 6, 2019 (In 18 days)
Pay Date Mon, Jul 1, 2019
History 114 Payments (Quarterly)

BAX Charts

$61.45
52 Week Range
$81.77
Dec 24, 2018
Apr 1, 2019

75.98 39.23 26.63 1.16 BAX NYSE -1.20 16.36 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BAX&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BAX&exchange=NYSE&chart=1

Becton Dickinson and Co [BDX]
$228.36 2.43 (1.08%)

BDX Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 60.80 Billion
BDX Description

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. International revenue accounts for 45% of the company's business. With CareFusion, BD has entered into medical systems (such as infusion pumps and ventilators) as well as procedural solutions businesses. The Bard deal gives the company a presence in urology, vascular, and oncology.


Visit Website

BDX Earnings

EPS 2.09 P/E Ratio 72.20
Previous Earnings Tue, Feb 5, 2019
Latest Earnings Thu, May 9, 2019 (10 days ago)

BDX Dividend

Yield 1.35% / $3.08
Ex-Date Thu, Jun 6, 2019 (In 18 days)
Pay Date Fri, Jun 28, 2019
History 135 Payments (Quarterly)

BDX Charts

$209.85
52 Week Range
$264.38
Dec 24, 2018
Oct 1, 2018

228.36 60.80 72.20 1.35 BDX NYSE 1.08 3.76 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BDX&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BDX&exchange=NYSE&chart=1

Biogen Inc [BIIB]
$229.28 1.59 (0.69%)

BIIB Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 44.91 Billion
BIIB Description

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Tysabri and Tecfidera. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.


Visit Website

BIIB Earnings

EPS 7.17 P/E Ratio 10.77
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Wed, Apr 24, 2019 (25 days ago)

BIIB Dividend

Yield --
Ex-Date --
Pay Date --
History --

BIIB Charts

$216.71
52 Week Range
$383.83
Mar 22, 2019
Jul 25, 2018

229.28 44.91 10.77 0.00 BIIB NASDAQ -0.69 -24.75 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BIIB&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BIIB&exchange=NASDAQ&chart=1

BioMarin Pharmaceutical Inc [BMRN]
$88.71 0.96 (1.07%)

BMRN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 16.15 Billion
BMRN Description

BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials.


Visit Website

BMRN Earnings

EPS -0.32 P/E Ratio 0.00
Previous Earnings Thu, Feb 21, 2019
Latest Earnings Thu, Apr 25, 2019 (24 days ago)

BMRN Dividend

Yield --
Ex-Date --
Pay Date --
History --

BMRN Charts

$80.14
52 Week Range
$106.07
Dec 24, 2018
Oct 17, 2018

88.71 16.15 0.00 0.00 BMRN NASDAQ -1.07 4.41 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BMRN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BMRN&exchange=NASDAQ&chart=1

Bristol-Myers Squibb Co [BMY]
$46.85 0.27 (0.57%)

BMY Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 76.27 Billion
BMY Description

Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs.


Visit Website

BMY Earnings

EPS 1.05 P/E Ratio 15.35
Previous Earnings Thu, Jan 24, 2019
Latest Earnings Thu, Apr 25, 2019 (24 days ago)

BMY Dividend

Yield 3.50% / $1.64
Ex-Date Thu, Apr 4, 2019 (45 days ago)
Pay Date Wed, May 1, 2019
History 134 Payments (Quarterly)

BMY Charts

$44.62
52 Week Range
$63.23
Apr 24, 2019
Oct 9, 2018

46.85 76.27 15.35 3.50 BMY NYSE -0.57 -9.94 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BMY&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BMY&exchange=NYSE&chart=1

Boston Scientific Corp [BSX]
$37.32 0.30 (0.80%)

BSX Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 52.32 Billion
BSX Description

Boston Scientific Corp produces less-invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract tests, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.


Visit Website

BSX Earnings

EPS 0.31 P/E Ratio 32.07
Previous Earnings Wed, Feb 6, 2019
Latest Earnings Wed, Apr 24, 2019 (25 days ago)

BSX Dividend

Yield --
Ex-Date --
Pay Date --
History --

BSX Charts

$30.20
52 Week Range
$40.75
May 29, 2018
Mar 1, 2019

37.32 52.32 32.07 0.00 BSX NYSE -0.80 8.30 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BSX&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BSX&exchange=NYSE&chart=1

Cardinal Health Inc [CAH]
$45.03 0.20 (0.44%)

CAH Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 13.70 Billion
CAH Description

Cardinal Health is the third-largest global logistics provider engaged in wholesale pharmaceutical and medical products. Similar to the other two peers, the company has evolved over time and has become entrenched in the sourcing and distribution of brand-name and generic pharmaceuticals and related services to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. Through acquisitions, Cardinal Health has the ability to manufacture commodity products and certain medical devices.


Visit Website

CAH Earnings

EPS 0.99 P/E Ratio 21.92
Previous Earnings Thu, Feb 7, 2019
Latest Earnings Thu, May 9, 2019 (10 days ago)

CAH Dividend

Yield 4.27% / $1.92
Ex-Date Fri, Jun 28, 2019 (In 40 days)
Pay Date Mon, Jul 15, 2019
History 138 Payments (Quarterly)

CAH Charts

$42.93
52 Week Range
$57.63
Dec 24, 2018
Nov 15, 2018

45.03 13.70 21.92 4.27 CAH NYSE -0.44 -0.09 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CAH&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CAH&exchange=NYSE&chart=1

Celgene Corp [CELG]
$95.42 0.09 (0.09%)

CELG Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 67.36 Billion
CELG Description

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.


Visit Website

CELG Earnings

EPS 2.20 P/E Ratio 17.70
Previous Earnings Thu, Jan 31, 2019
Latest Earnings Thu, Apr 25, 2019 (24 days ago)

CELG Dividend

Yield --
Ex-Date --
Pay Date --
History --

CELG Charts

$59.21
52 Week Range
$96.88
Dec 24, 2018
May 3, 2019

95.42 67.36 17.70 0.00 CELG NASDAQ -0.09 43.19 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CELG&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CELG&exchange=NASDAQ&chart=1

Cigna Corp [CI]
$154.86 1.07 (0.70%)

CI Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 59.56 Billion
CI Description

Long a leader in the self-funded employer health insurance market, Cigna has expanded its reach both organically and through the recent merger with Express Scripts. The firm now operates more on par with its peers, having both a medical and pharmaceutical benefits capability that should help level the playing field in the years to come. In addition, the firm is a leader in accident, disability, and life insurance globally, although these businesses have become much less important to the overall enterprise after the Express Scripts merger to bulk up its healthcare offering.


Visit Website

CI Earnings

EPS 3.61 P/E Ratio 18.86
Previous Earnings Fri, Feb 1, 2019
Latest Earnings Thu, May 2, 2019 (17 days ago)

CI Dividend

Yield 0.03% / $0.04
Ex-Date Fri, Mar 8, 2019 (72 days ago)
Pay Date Wed, Apr 10, 2019
History 101 Payments (Quarterly)

CI Charts

$145.49
52 Week Range
$224.84
Apr 17, 2019
Dec 3, 2018

154.86 59.56 18.86 0.03 CI NYSE 0.70 -17.26 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CI&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CI&exchange=NYSE&chart=1

Centene Corp [CNC]
$56.04 0.47 (0.85%)

CNC Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 23.10 Billion
CNC Description

Centene Corp offers healthcare plans to the United States government-sponsored healthcare programs, with a focus on uninsured individuals. It helps members access care, coordinates referrals to health and social services, and provides education and outreach programs to help its members select healthcare services. Centene's managed care segment provides health plan coverage to individuals through government subsidized programs, including Medicare and Medicaid. The specialty services segment consists of specialty companies offering healthcare services and products to state programs, correctional facilities, healthcare organizations, and other commercial organizations. The managed care segment contributes to the vast majority of the firm's overall revenue.


Visit Website

CNC Earnings

EPS 1.26 P/E Ratio 28.45
Previous Earnings Tue, Apr 23, 2019
Latest Earnings Tue, Jul 23, 2019 (In 65 days)

CNC Dividend

Yield --
Ex-Date --
Pay Date --
History --

CNC Charts

$47.01
52 Week Range
$73.44
Apr 17, 2019
Aug 29, 2018

56.04 23.10 28.45 0.00 CNC NYSE 0.85 -0.81 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CNC&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CNC&exchange=NYSE&chart=1

Quest Diagnostics Inc [DGX]
$97.23 0.84 (0.87%)

DGX Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 13.06 Billion
DGX Description

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates about 90% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing at its national network of 2,000 patient service centers. The firm also runs a diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.


Visit Website

DGX Earnings

EPS 1.22 P/E Ratio 14.27
Previous Earnings Thu, Feb 14, 2019
Latest Earnings Tue, Apr 23, 2019 (26 days ago)

DGX Dividend

Yield 2.18% / $2.12
Ex-Date Fri, Jul 5, 2019 (In 47 days)
Pay Date Mon, Jul 22, 2019
History 63 Payments (Quarterly)

DGX Charts

$79.75
52 Week Range
$114.99
Dec 24, 2018
Jul 19, 2018

97.23 13.06 14.27 2.18 DGX NYSE 0.87 18.33 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DGX&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DGX&exchange=NYSE&chart=1

Danaher Corp [DHR]
$131.10 1.17 (0.88%)

DHR Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 94.98 Billion
DHR Description

After the spin-off of Fortive in 2016, Danaher is a diversified and mostly healthcare-focused instrument and supplies manufacturer. After the spin, Danaher retains four main business segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. Each segment represents approximately 31%, 32%, 15%, and 22% of revenue, respectively.


Visit Website

DHR Earnings

EPS 0.46 P/E Ratio 26.35
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Thu, Apr 18, 2019 (31 days ago)

DHR Dividend

Yield 0.52% / $0.68
Ex-Date Thu, Jun 27, 2019 (In 39 days)
Pay Date Fri, Jul 26, 2019
History 106 Payments (Quarterly)

DHR Charts

$94.85
52 Week Range
$134.58
Dec 24, 2018
May 3, 2019

131.10 94.98 26.35 0.52 DHR NYSE -0.88 30.45 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DHR&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DHR&exchange=NYSE&chart=1

DaVita HealthCare Partners Inc [DVA]
$49.23 0.77 (1.54%)

DVA Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 8.41 Billion
DVA Description

DaVita Inc is the largest provider of dialysis services in the U.S., boasting market share levels that eclipse 35% measured by both patients and clinics. The firm operates 2,905 facilities worldwide, with 2,664 located in the United States, and treats over 225,000 patients globally each year. Management began to build out a fledgling international business in 2011, but we anticipate this business will need to continue to expand before it garners the scale needed to earn attractive returns. Government payers dominate dialysis reimbursement--DaVita receives approximately 69% of U.S. sales at Medicare and Medicaid reimbursement rates, with the remaining 31% coming from commercial insurers.


Visit Website

DVA Earnings

EPS -0.90 P/E Ratio 16.88
Previous Earnings Wed, Feb 13, 2019
Latest Earnings Tue, May 7, 2019 (12 days ago)

DVA Dividend

Yield --
Ex-Date --
Pay Date --
History --

DVA Charts

$48.73
52 Week Range
$76.08
Dec 24, 2018
Nov 7, 2018

49.23 8.41 16.88 0.00 DVA NYSE -1.54 -4.83 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DVA&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DVA&exchange=NYSE&chart=1

Endo International PLC [ENDP]
$6.52 0.08 (1.21%)

ENDP Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 1.49 Billion
ENDP Description

After a string of acquisitions and divestitures, Endo is a specialty pharmaceutical company with a considerable presence in pain management. The acquisitions of Auxilium and Par increased the company's presence in urology and generics, respectively.


Visit Website

ENDP Earnings

EPS -0.08 P/E Ratio 0.00
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Thu, May 9, 2019 (10 days ago)

ENDP Dividend

Yield --
Ex-Date --
Pay Date --
History --

ENDP Charts

$5.95
52 Week Range
$18.30
May 22, 2018
Oct 16, 2018

6.52 1.49 0.00 0.00 ENDP NASDAQ -1.21 -15.43 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ENDP&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ENDP&exchange=NASDAQ&chart=1

Express Scripts Holding Co [ESRX]
$92.51 0.18 (0.19%)

ESRX Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 52.16 Billion
ESRX Description

Express Scripts is the largest pharmacy benefit manager in the United States. Through its mail-order pharmacy and network of retail pharmacies, Express Scripts processes approximately 1.4 billion adjusted prescriptions annually for its payer clients.


Visit Website

ESRX Earnings

EPS 1.90 P/E Ratio 11.56
Previous Earnings --
Latest Earnings Wed, Oct 31, 2018 (200 days ago)

ESRX Dividend

Yield --
Ex-Date --
Pay Date --
History --

ESRX Charts

$74.44
52 Week Range
$101.47
Aug 1, 2018
Nov 30, 2018

92.51 52.16 11.56 0.00 ESRX NASDAQ 0.19 -60.31 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ESRX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ESRX&exchange=NASDAQ&chart=1

Edwards Lifesciences Corp [EW]
$173.12 4.02 (2.27%)

EW Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 36.84 Billion
EW Description

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters and retractors, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.


Visit Website

EW Earnings

EPS 1.20 P/E Ratio 49.23
Previous Earnings Thu, Jan 31, 2019
Latest Earnings Tue, Apr 23, 2019 (26 days ago)

EW Dividend

Yield --
Ex-Date --
Pay Date --
History --

EW Charts

$135.93
52 Week Range
$192.15
May 29, 2018
Mar 21, 2019

173.12 36.84 49.23 0.00 EW NYSE -2.27 16.00 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EW&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EW&exchange=NYSE&chart=1

Gilead Sciences Inc [GILD]
$66.36 0.58 (0.88%)

GILD Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 83.64 Billion
GILD Description

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.


Visit Website

GILD Earnings

EPS 1.55 P/E Ratio 55.20
Previous Earnings Mon, Feb 4, 2019
Latest Earnings Thu, May 2, 2019 (17 days ago)

GILD Dividend

Yield 3.44% / $2.28
Ex-Date Thu, Dec 13, 2018 (157 days ago)
Pay Date Fri, Dec 28, 2018
History 15 Payments (Quarterly)

GILD Charts

$60.54
52 Week Range
$79.00
Dec 24, 2018
Oct 3, 2018

66.36 83.64 55.20 3.44 GILD NASDAQ 0.88 4.60 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GILD&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GILD&exchange=NASDAQ&chart=1

HCA Holdings Inc [HCA]
$123.51 0.81 (0.66%)

HCA Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 42.17 Billion
HCA Description

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. The firm owns and operates 179 hospitals and 120 outpatient surgery centers with more than 1,800 alternate site locations including physician offices, urgent care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.


Visit Website

HCA Earnings

EPS 3.03 P/E Ratio 10.81
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Tue, Apr 30, 2019 (19 days ago)

HCA Dividend

Yield 1.30% / $1.60
Ex-Date Fri, May 31, 2019 (In 12 days)
Pay Date Fri, Jun 28, 2019
History 9 Payments (Quarterly)

HCA Charts

$102.60
52 Week Range
$146.29
Jun 29, 2018
Dec 3, 2018

123.51 42.17 10.81 1.30 HCA NYSE 0.66 1.44 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HCA&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HCA&exchange=NYSE&chart=1

Hologic, Inc [HOLX]
$44.87 0.20 (0.44%)

HOLX Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 12.18 Billion
HOLX Description

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: breast health (38% of sales), diagnostics (26%) surgical (13%), medical aesthetics (10%), and skeletal health (3%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics, and the purchase of Cynosure establishes a footprint in the cosmetic laser market. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%), Asia (9%), and other international markets (5%). Hologic is headquartered in Bedford, Massachusetts.


Visit Website

HOLX Earnings

EPS -1.01 P/E Ratio 0.00
Previous Earnings Wed, Jan 30, 2019
Latest Earnings Wed, May 1, 2019 (18 days ago)

HOLX Dividend

Yield --
Ex-Date --
Pay Date --
History --

HOLX Charts

$37.76
52 Week Range
$48.40
Dec 24, 2018
Mar 29, 2019

44.87 12.18 0.00 0.00 HOLX NASDAQ -0.44 16.79 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HOLX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HOLX&exchange=NASDAQ&chart=1

Henry Schein Inc [HSIC]
$67.92 0.83 (1.24%)

HSIC Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 9.93 Billion
HSIC Description

Henry Schein is one of the largest wholesalers of dental and medical products in the United States. The firm has a focus on dental practice and medical products. It also offers dental practice management products that include software products, technical, financial, and educational services to thousands of dental practices throughout North America.


Visit Website

HSIC Earnings

EPS 0.73 P/E Ratio 17.64
Previous Earnings Wed, Feb 20, 2019
Latest Earnings Tue, May 7, 2019 (12 days ago)

HSIC Dividend

Yield --
Ex-Date --
Pay Date --
History --

HSIC Charts

$54.25
52 Week Range
$70.87
May 31, 2018
Dec 3, 2018

67.92 9.93 17.64 0.00 HSIC NASDAQ 1.24 13.43 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HSIC&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HSIC&exchange=NASDAQ&chart=1

Humana Inc [HUM]
$247.82 5.60 (2.31%)

HUM Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 32.71 Billion
HUM Description

Humana is one of the largest private insurance organizations participating in the Medicare Advantage program. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's TRICARE program. Additionally, the firm is a leader in stand-alone prescription drug plans offered to seniors enrolled in traditional fee-for-service Medicare. In addition, the firm has a nascent commercial offering focusing on risk arrangements alongside specialty offerings such as dental, vision, and life for smaller employers.


Visit Website

HUM Earnings

EPS 4.18 P/E Ratio 19.79
Previous Earnings Wed, Feb 6, 2019
Latest Earnings Wed, May 1, 2019 (18 days ago)

HUM Dividend

Yield 0.89% / $2.20
Ex-Date Thu, Jun 27, 2019 (In 39 days)
Pay Date Fri, Jul 26, 2019
History 47 Payments (Quarterly)

HUM Charts

$232.89
52 Week Range
$353.98
Apr 17, 2019
Nov 7, 2018

247.82 32.71 19.79 0.89 HUM NYSE 2.31 -11.99 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HUM&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HUM&exchange=NYSE&chart=1

IDEXX Laboratories, Inc [IDXX]
$249.56 2.41 (0.96%)

IDXX Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 21.46 Billion
IDXX Description

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. Idexx gets about 39% of its revenue from outside the United States.


Visit Website

IDXX Earnings

EPS 1.19 P/E Ratio 51.29
Previous Earnings Fri, Feb 1, 2019
Latest Earnings Wed, May 1, 2019 (18 days ago)

IDXX Dividend

Yield --
Ex-Date --
Pay Date --
History --

IDXX Charts

$176.18
52 Week Range
$254.46
Dec 24, 2018
Aug 29, 2018

249.56 21.46 51.29 0.00 IDXX NASDAQ -0.96 36.78 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IDXX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IDXX&exchange=NASDAQ&chart=1

Illumina Inc [ILMN]
$307.63 2.22 (0.72%)

ILMN Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 45.07 Billion
ILMN Description

Illumina is a major player in life science tools for analyzing genetic material. Revenue from microarray and genome sequencing machines and disposables make up most of the company's revenue, but approximately 18% of the company's sales come from testing services. Essentially all of Illumina's growth stems from the company's genome sequencing products, which include the company's high-throughput NovaSeq and HiSeq instruments in addition to its benchtop NextSeq, MiSeq, and MiniSeq, and iSeq product lines.


Visit Website

ILMN Earnings

EPS 1.58 P/E Ratio 57.38
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Thu, Apr 25, 2019 (24 days ago)

ILMN Dividend

Yield --
Ex-Date --
Pay Date --
History --

ILMN Charts

$266.22
52 Week Range
$367.06
May 25, 2018
Sep 28, 2018

307.63 45.07 57.38 0.00 ILMN NASDAQ -0.72 4.45 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ILMN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ILMN&exchange=NASDAQ&chart=1

Incyte Corp [INCY]
$77.20 0.44 (0.57%)

INCY Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 16.30 Billion
INCY Description

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant, which Eli Lilly licenses, and oncology drug Iclusig for chronic myeloid leukemia. Incyte's pipeline includes a broad array of oncology and autoimmune programs, including next-generation JAK inhibitor itacitinib.


Visit Website

INCY Earnings

EPS 0.48 P/E Ratio 145.02
Previous Earnings Thu, Feb 14, 2019
Latest Earnings Tue, Apr 30, 2019 (19 days ago)

INCY Dividend

Yield --
Ex-Date --
Pay Date --
History --

INCY Charts

$58.50
52 Week Range
$88.17
Dec 24, 2018
Mar 1, 2019

77.20 16.30 145.02 0.00 INCY NASDAQ -0.57 21.46 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=INCY&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=INCY&exchange=NASDAQ&chart=1

Intuitive Surgical Inc [ISRG]
$490.14 1.59 (0.32%)

ISRG Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 56.47 Billion
ISRG Description

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 5,000 da Vinci systems in hospitals worldwide, with 3,200 installations in the United States and a growing number in emerging markets.


Visit Website

ISRG Earnings

EPS 2.67 P/E Ratio 51.10
Previous Earnings Thu, Jan 24, 2019
Latest Earnings Thu, Apr 18, 2019 (31 days ago)

ISRG Dividend

Yield --
Ex-Date --
Pay Date --
History --

ISRG Charts

$434.89
52 Week Range
$585.89
Dec 24, 2018
Apr 10, 2019

490.14 56.47 51.10 0.00 ISRG NASDAQ -0.32 5.17 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ISRG&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ISRG&exchange=NASDAQ&chart=1

Johnson & Johnson [JNJ]
$138.61 0.40 (0.29%)

JNJ Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 366.96 Billion
JNJ Description

Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, close to half of total revenue is generated in the United States.


Visit Website

JNJ Earnings

EPS 1.41 P/E Ratio 24.34
Previous Earnings Tue, Apr 16, 2019
Latest Earnings Tue, Jul 16, 2019 (In 58 days)

JNJ Dividend

Yield 2.74% / $3.80
Ex-Date Fri, May 24, 2019 (In 5 days)
Pay Date Tue, Jun 11, 2019
History 190 Payments (Quarterly)

JNJ Charts

$119.40
52 Week Range
$147.84
May 29, 2018
Dec 13, 2018

138.61 366.96 24.34 2.74 JNJ NYSE 0.29 8.50 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=JNJ&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=JNJ&exchange=NYSE&chart=1

Laboratory Corp of America Holdings [LH]
$164.41 0.58 (0.35%)

LH Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 16.29 Billion
LH Description

Laboratory Corporation of America is the nation's second- largest independent clinical laboratory, with roughly 20% of the independent lab market. The company operates more than 1,800 patient-service centers, offering a broad range of clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.


Visit Website

LH Earnings

EPS 1.88 P/E Ratio 18.48
Previous Earnings Thu, Feb 7, 2019
Latest Earnings Wed, Mar 27, 2019 (53 days ago)

LH Dividend

Yield --
Ex-Date --
Pay Date --
History 15 Payments (Quarterly)

LH Charts

$120.82
52 Week Range
$189.41
Dec 24, 2018
Jun 15, 2018

164.41 16.29 18.48 0.00 LH NYSE -0.35 30.04 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LH&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LH&exchange=NYSE&chart=1

Eli Lilly & Co [LLY]
$116.01 0.72 (0.62%)

LLY Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 113.93 Billion
LLY Description

Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.


Visit Website

LLY Earnings

EPS 4.33 P/E Ratio 40.60
Previous Earnings Tue, Apr 30, 2019
Latest Earnings Tue, Jul 30, 2019 (In 72 days)

LLY Dividend

Yield 2.22% / $2.58
Ex-Date Thu, May 16, 2019 (3 days ago)
Pay Date Mon, Jun 10, 2019
History 134 Payments (Quarterly)

LLY Charts

$81.83
52 Week Range
$131.02
May 21, 2018
Mar 26, 2019

116.01 113.93 40.60 2.22 LLY NYSE -0.62 0.98 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LLY&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LLY&exchange=NYSE&chart=1

McKesson Corp [MCK]
$125.00 0.58 (0.46%)

MCK Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 24.23 Billion
MCK Description

McKesson Corporation is the largest and most complex of the leading third-party logistics providers. The company is engaged in wholesale pharmaceutical and medical products sourcing, distribution and dispensing, contract manufacturing, and related IT services to acute care hospitals and health systems, independent and chain retail pharmacies in North America, Europe, and Canada. Through acquisition and joint ventures McKesson also runs the fourth largest pharmacy chain and provides technology and consulting services to manufacturers, pharmacies, physician offices, surgery centers, long-term care facilities, and home healthcare businesses.


Visit Website

MCK Earnings

EPS -4.17 P/E Ratio 0.00
Previous Earnings Thu, Jan 31, 2019
Latest Earnings Wed, May 8, 2019 (11 days ago)

MCK Dividend

Yield 1.25% / $1.56
Ex-Date Fri, May 31, 2019 (In 12 days)
Pay Date Mon, Jul 1, 2019
History 142 Payments (Quarterly)

MCK Charts

$108.23
52 Week Range
$150.00
Dec 24, 2018
Jun 14, 2018

125.00 24.23 0.00 1.25 MCK NYSE -0.46 10.55 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MCK&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MCK&exchange=NYSE&chart=1

Medtronic PLC [MDT]
$87.73 0.38 (0.43%)

MDT Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 119.23 Billion
MDT Description

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for about 45% of the company's total sales.


Visit Website

MDT Earnings

EPS 0.95 P/E Ratio 24.06
Previous Earnings Tue, Feb 19, 2019
Latest Earnings Thu, May 23, 2019 (In 4 days)

MDT Dividend

Yield 2.28% / $2.00
Ex-Date Thu, Mar 21, 2019 (59 days ago)
Pay Date Fri, Apr 12, 2019
History 136 Payments (Quarterly)

MDT Charts

$82.45
52 Week Range
$99.49
Jan 7, 2019
Oct 1, 2018

87.73 119.23 24.06 2.28 MDT NYSE -0.43 -0.22 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MDT&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MDT&exchange=NYSE&chart=1

Mallinckrodt PLC [MNK]
$14.68 0.48 (3.17%)

MNK Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 1.27 Billion
MNK Description

Mallinckrodt PLC is a specialty pharmaceutical company that was spun off from Covidien and historically focused on pain therapeutics. After recently moving its generics business into discontinued operations, Mallinckrodt now focuses entirely on branded drugs following the sale of its nuclear imaging business in 2016. Mallinckrodt's products now span a number of therapeutic areas, but a significant portion focus on hospital and clinical customers.


Visit Website

MNK Earnings

EPS 1.86 P/E Ratio 0.00
Previous Earnings Tue, Feb 26, 2019
Latest Earnings Tue, May 7, 2019 (12 days ago)

MNK Dividend

Yield --
Ex-Date --
Pay Date --
History --

MNK Charts

$14.68
52 Week Range
$36.08
May 17, 2019
Aug 23, 2018

14.68 1.27 0.00 0.00 MNK NYSE -3.17 -11.51 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MNK&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MNK&exchange=NYSE&chart=1

Merck & Co Inc [MRK]
$78.72 0.41 (0.52%)

MRK Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 204.68 Billion
MRK Description

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the company's sales are generated in the United States.


Visit Website

MRK Earnings

EPS 1.13 P/E Ratio 33.85
Previous Earnings Tue, Apr 30, 2019
Latest Earnings Tue, Jul 30, 2019 (In 72 days)

MRK Dividend

Yield 2.79% / $2.20
Ex-Date Thu, Mar 14, 2019 (66 days ago)
Pay Date Fri, Apr 5, 2019
History 134 Payments (Quarterly)

MRK Charts

$58.40
52 Week Range
$83.30
May 29, 2018
Apr 1, 2019

78.72 204.68 33.85 2.79 MRK NYSE -0.52 4.14 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MRK&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MRK&exchange=NYSE&chart=1

Mettler-Toledo International Inc [MTD]
$726.42 18.56 (2.49%)

MTD Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 17.84 Billion
MTD Description

Mettler-Toledo International Inc supplies weighing and precision instruments to customers in the life sciences (50% of sales), industrial (42%), and food retail industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances.


Visit Website

MTD Earnings

EPS 4.50 P/E Ratio 38.09
Previous Earnings Thu, Feb 7, 2019
Latest Earnings Thu, May 9, 2019 (10 days ago)

MTD Dividend

Yield --
Ex-Date --
Pay Date --
History --

MTD Charts

$513.56
52 Week Range
$762.43
Jan 3, 2019
May 3, 2019

726.42 17.84 38.09 0.00 MTD NYSE -2.49 33.03 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MTD&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MTD&exchange=NYSE&chart=1

Mylan NV [MYL]
$19.64 0.57 (2.82%)

MYL Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 10.33 Billion
MYL Description

Mylan is one of the world's largest generic pharmaceutical manufacturers with operations in the United States, Europe, Asia, Middle East, Africa, and Australia. Generic drug sales constitute approximately 90% of revenue. Remaining sales come from a handful of branded products, primarily epinephrine injector EpiPen. Mylan also owns Matrix, an Indian active pharmaceutical ingredient manufacturer.


Visit Website

MYL Earnings

EPS -0.05 P/E Ratio 28.88
Previous Earnings Tue, Feb 26, 2019
Latest Earnings Tue, May 7, 2019 (12 days ago)

MYL Dividend

Yield --
Ex-Date --
Pay Date --
History 73 Payments (Quarterly)

MYL Charts

$19.64
52 Week Range
$41.86
May 17, 2019
Jun 12, 2018

19.64 10.33 28.88 0.00 MYL NASDAQ -2.82 -29.66 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MYL&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MYL&exchange=NASDAQ&chart=1

Patterson Cos Inc [PDCO]
$22.05 0.10 (0.45%)

PDCO Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 2.10 Billion
PDCO Description

Patterson is one of the largest distributors and wholesalers of dental and animal health products, equipment, and devices in the United States. The firm offers dental practice management products, including office software products, technical, financial, and educational services, to thousands of dental practices throughout North America. It also is a major supplier of animal health products to vets and production companies in the United Kingdom.


Visit Website

PDCO Earnings

EPS 0.34 P/E Ratio 13.70
Previous Earnings Thu, Nov 29, 2018
Latest Earnings Thu, Feb 28, 2019 (80 days ago)

PDCO Dividend

Yield 4.72% / $1.04
Ex-Date Thu, Apr 11, 2019 (38 days ago)
Pay Date Fri, Apr 26, 2019
History 37 Payments (Quarterly)

PDCO Charts

$19.34
52 Week Range
$26.16
Dec 24, 2018
Nov 27, 2018

22.05 2.10 13.70 4.72 PDCO NASDAQ -0.45 9.76 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PDCO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PDCO&exchange=NASDAQ&chart=1

Pfizer Inc [PFE]
$41.47 0.17 (0.41%)

PFE Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 231.52 Billion
PFE Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drugs Enbrel and Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total company sales.


Visit Website

PFE Earnings

EPS 0.69 P/E Ratio 11.28
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Tue, Apr 30, 2019 (19 days ago)

PFE Dividend

Yield 3.47% / $1.44
Ex-Date Thu, May 9, 2019 (10 days ago)
Pay Date Fri, Jun 7, 2019
History 134 Payments (Quarterly)

PFE Charts

$35.64
52 Week Range
$46.23
May 18, 2018
Nov 30, 2018

41.47 231.52 11.28 3.47 PFE NYSE -0.41 -4.12 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PFE&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PFE&exchange=NYSE&chart=1

PerkinElmer Inc [PKI]
$85.94 2.05 (2.33%)

PKI Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 9.75 Billion
PKI Description

PerkinElmer provides instruments, consumables, and services to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes prenatal screening and infectious disease testing, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening to environmental analytical tools.


Visit Website

PKI Earnings

EPS 0.32 P/E Ratio 75.48
Previous Earnings Thu, Jan 31, 2019
Latest Earnings Thu, Apr 25, 2019 (24 days ago)

PKI Dividend

Yield 0.33% / $0.28
Ex-Date Thu, Jul 18, 2019 (In 60 days)
Pay Date Fri, Aug 9, 2019
History 136 Payments (Quarterly)

PKI Charts

$71.87
52 Week Range
$101.12
Dec 24, 2018
Apr 9, 2019

85.94 9.75 75.48 0.33 PKI NYSE -2.33 11.73 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PKI&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PKI&exchange=NYSE&chart=1

Perrigo Co PLC [PRGO]
$49.67 0.23 (0.46%)

PRGO Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 6.76 Billion
PRGO Description

Perrigo is the largest store-brand over-the-counter pharmaceutical and infant formula manufacturer. The company operates three major segments: consumer healthcare, branded consumer healthcare, and prescription pharmaceuticals. As of mid-2018, Perrigo plans to divest the prescription segment. In the United States, Perrigo sells about 2,100 products with 9,000 stock-keeping units. Following the acquisition of Omega Pharma, approximately 30% of the company's revenue comes from outside the U.S.


Visit Website

PRGO Earnings

EPS 0.59 P/E Ratio 67.25
Previous Earnings Wed, Feb 27, 2019
Latest Earnings Wed, May 8, 2019 (11 days ago)

PRGO Dividend

Yield 1.69% / $0.84
Ex-Date Thu, May 30, 2019 (In 11 days)
Pay Date Tue, Jun 18, 2019
History 66 Payments (Quarterly)

PRGO Charts

$36.50
52 Week Range
$80.52
Dec 24, 2018
Jul 31, 2018

49.67 6.76 67.25 1.69 PRGO NYSE -0.46 22.64 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PRGO&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PRGO&exchange=NYSE&chart=1

Regeneron Pharmaceuticals Inc [REGN]
$304.94 3.10 (1.01%)

REGN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 33.96 Billion
REGN Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis and asthma; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.


Visit Website

REGN Earnings

EPS 4.23 P/E Ratio 24.20
Previous Earnings Wed, Feb 6, 2019
Latest Earnings Tue, May 7, 2019 (12 days ago)

REGN Dividend

Yield --
Ex-Date --
Pay Date --
History --

REGN Charts

$293.74
52 Week Range
$439.57
May 25, 2018
Mar 1, 2019

304.94 33.96 24.20 0.00 REGN NASDAQ -1.01 -18.12 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=REGN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=REGN&exchange=NASDAQ&chart=1

Stryker Corp [SYK]
$184.14 1.49 (0.80%)

SYK Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 69.98 Billion
SYK Description

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Approximately 35% of Stryker's total revenue currently comes from outside the United States.


Visit Website

SYK Earnings

EPS 1.10 P/E Ratio 53.35
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Tue, Apr 23, 2019 (26 days ago)

SYK Dividend

Yield 1.13% / $2.08
Ex-Date Thu, Jun 27, 2019 (In 39 days)
Pay Date Wed, Jul 31, 2019
History 58 Payments (Quarterly)

SYK Charts

$145.00
52 Week Range
$198.00
Dec 24, 2018
Mar 21, 2019

184.14 69.98 53.35 1.13 SYK NYSE -0.80 19.18 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SYK&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SYK&exchange=NYSE&chart=1

Thermo Fisher Scientific Inc [TMO]
$261.73 5.29 (1.98%)

TMO Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 106.80 Billion
TMO Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments: analytical technologies (23% of sales); specialty diagnostic products (15%); life science solutions (26%); and lab products and services (41%).


Visit Website

TMO Earnings

EPS 2.04 P/E Ratio 35.21
Previous Earnings Wed, Jan 30, 2019
Latest Earnings Wed, Apr 24, 2019 (25 days ago)

TMO Dividend

Yield 0.29% / $0.76
Ex-Date Thu, Mar 14, 2019 (66 days ago)
Pay Date Tue, Apr 16, 2019
History 30 Payments (Quarterly)

TMO Charts

$203.38
52 Week Range
$280.65
Jun 27, 2018
Apr 12, 2019

261.73 106.80 35.21 0.29 TMO NYSE -1.98 19.28 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TMO&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TMO&exchange=NYSE&chart=1

Universal Health Services Inc [UHS]
$121.88 0.18 (0.15%)

UHS Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 10.98 Billion
UHS Description

Universal Health Services owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers. Each segment contributes roughly half of the firm's overall revenue. Universal Health Services receives a significant portion of its net patient revenue from Medicare and Medicaid. The largest proportion of the firm's net patient revenue is paid by managed care organizations.


Visit Website

UHS Earnings

EPS 2.57 P/E Ratio 14.98
Previous Earnings Wed, Feb 27, 2019
Latest Earnings Thu, Apr 25, 2019 (24 days ago)

UHS Dividend

Yield 0.33% / $0.40
Ex-Date Fri, May 31, 2019 (In 12 days)
Pay Date Mon, Jun 17, 2019
History 64 Payments (Quarterly)

UHS Charts

$110.98
52 Week Range
$140.80
Jul 2, 2018
Mar 1, 2019

121.88 10.98 14.98 0.33 UHS NYSE 0.15 3.78 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=UHS&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=UHS&exchange=NYSE&chart=1

UnitedHealth Group Inc [UNH]
$241.38 4.59 (1.94%)

UNH Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 224.36 Billion
UNH Description

UnitedHealth Group is the largest private health insurance provider in the United States, offering medical benefits to nearly 50 million members across its U.S. and international businesses. As the leader in employer-sponsored, self-directed, and government-backed insurance plans, United has obtained unrivaled scale compared with its peers in managed care. Along with its insurance assets, United's continued investment behind its Optum franchises has created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.


Visit Website

UNH Earnings

EPS 3.62 P/E Ratio 17.22
Previous Earnings Tue, Jan 15, 2019
Latest Earnings Tue, Apr 16, 2019 (33 days ago)

UNH Dividend

Yield 1.49% / $3.60
Ex-Date Fri, Mar 8, 2019 (72 days ago)
Pay Date Tue, Mar 19, 2019
History 57 Payments (Quarterly)

UNH Charts

$216.84
52 Week Range
$286.33
Apr 17, 2019
Dec 3, 2018

241.38 224.36 17.22 1.49 UNH NYSE 1.94 -0.87 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=UNH&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=UNH&exchange=NYSE&chart=1

Varian Medical Systems Inc [VAR]
$130.65 0.25 (0.19%)

VAR Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 11.88 Billion
VAR Description

Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (52%), followed by Europe, the Middle East, and Africa (29%) and Asia-Pacific (20%).


Visit Website

VAR Earnings

EPS 0.97 P/E Ratio 33.03
Previous Earnings Wed, Jan 23, 2019
Latest Earnings Wed, Apr 24, 2019 (25 days ago)

VAR Dividend

Yield --
Ex-Date --
Pay Date --
History 61 Payments (Quarterly)

VAR Charts

$103.97
52 Week Range
$141.98
Oct 11, 2018
Apr 2, 2019

130.65 11.88 33.03 0.00 VAR NYSE -0.19 15.96 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VAR&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VAR&exchange=NYSE&chart=1

Vertex Pharmaceuticals Inc [VRTX]
$168.73 1.50 (0.88%)

VRTX Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 43.91 Billion
VRTX Description

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, and Symdeko for cystic fibrosis, in addition to several pipeline candidates targeting this market. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.


Visit Website

VRTX Earnings

EPS 1.05 P/E Ratio 20.79
Previous Earnings Tue, Feb 5, 2019
Latest Earnings Tue, Apr 30, 2019 (19 days ago)

VRTX Dividend

Yield --
Ex-Date --
Pay Date --
History --

VRTX Charts

$145.72
52 Week Range
$194.70
Jun 5, 2018
Jan 18, 2019

168.73 43.91 20.79 0.00 VRTX NASDAQ -0.88 2.83 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VRTX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VRTX&exchange=NASDAQ&chart=1

Waters Corp [WAT]
$208.20 1.92 (0.91%)

WAT Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 14.57 Billion
WAT Description

Waters provides analytical instruments for pharmaceutical, biochemical, and industrial customers. Waters leads the liquid chromatography market, which accounts for roughly 90% of total revenue. Remaining sales come from thermal analysis instruments. Instruments, consumables, informatics, and services account for approximately 40%, 16%, 11%, and 33% of sales, respectively.


Visit Website

WAT Earnings

EPS 1.52 P/E Ratio 31.32
Previous Earnings Wed, Jan 23, 2019
Latest Earnings Tue, Apr 23, 2019 (26 days ago)

WAT Dividend

Yield --
Ex-Date --
Pay Date --
History --

WAT Charts

$173.54
52 Week Range
$253.15
Dec 24, 2018
Apr 8, 2019

208.20 14.57 31.32 0.00 WAT NYSE -0.91 13.52 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=WAT&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=WAT&exchange=NYSE&chart=1

Health Care Select Sector SPDR [XLV]
$88.44 0.19 (0.21%)

XLV Profile

Sector Health Care
Industry --
Market Cap 14.39 Billion

XLV Earnings

EPS -- P/E Ratio --
Previous Earnings --
Latest Earnings --

XLV Dividend

Yield 1.54% / $1.36
Ex-Date Fri, Mar 15, 2019 (65 days ago)
Pay Date Wed, Mar 20, 2019
History 10 Payments (Quarterly)

XLV Charts

$80.70
52 Week Range
$95.87
Dec 24, 2018
Nov 30, 2018

88.44 14.39 -- 1.54 XLV AMEX -0.21 3.80 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=XLV&exchange=AMEX&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=XLV&exchange=AMEX&chart=1

DENTSPLY International Inc [XRAY]
$54.43 0.46 (0.84%)

XRAY Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 12.86 Billion
XRAY Description

Dentsply Sirona is one of the world's largest manufacturers and distributors of dental supplies and equipment. Its product segments include dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. Over half of its products are sold through dental distributors, and approximately 65% of Dentsply's sales are outside the U.S.


Visit Website

XRAY Earnings

EPS 0.18 P/E Ratio 0.00
Previous Earnings Fri, Mar 1, 2019
Latest Earnings Fri, May 3, 2019 (16 days ago)

XRAY Dividend

Yield 0.64% / $0.35
Ex-Date Thu, Mar 28, 2019 (52 days ago)
Pay Date Fri, Apr 12, 2019
History 100 Payments (Quarterly)

XRAY Charts

$34.32
52 Week Range
$55.05
Oct 29, 2018
May 3, 2019

54.43 12.86 0.00 0.64 XRAY NASDAQ -0.84 43.65 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=XRAY&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=XRAY&exchange=NASDAQ&chart=1

Zimmer Biomet Holdings Inc [ZBH]
$116.42 1.66 (1.41%)

ZBH Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 24.40 Billion
ZBH Description

Zimmer Biomet Holdings Inc designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 60% of total revenue is derived from sales of large joints, another 22% comes from extremities and trauma; the remaining portion is primarily related to spine and dental products.


Visit Website

ZBH Earnings

EPS 1.20 P/E Ratio 0.00
Previous Earnings Fri, Feb 1, 2019
Latest Earnings Fri, Apr 26, 2019 (23 days ago)

ZBH Dividend

Yield 0.82% / $0.96
Ex-Date Thu, Mar 28, 2019 (52 days ago)
Pay Date Tue, Apr 30, 2019
History 29 Payments (Quarterly)

ZBH Charts

$97.23
52 Week Range
$131.47
Dec 24, 2018
Sep 28, 2018

116.42 24.40 0.00 0.82 ZBH NYSE -1.41 13.82 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ZBH&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ZBH&exchange=NYSE&chart=1

Zoetis Inc [ZTS]
$101.97 0.96 (0.93%)

ZTS Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 48.75 Billion
ZTS Description

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns more than 55% of total revenue from production animals (cattle, pigs, poultry, and so on), and companion animal (dogs, horses, cats) products make up the remainder. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.


Visit Website

ZTS Earnings

EPS 0.65 P/E Ratio 34.56
Previous Earnings Thu, Feb 14, 2019
Latest Earnings Thu, May 2, 2019 (17 days ago)

ZTS Dividend

Yield 0.64% / $0.66
Ex-Date Thu, Jul 18, 2019 (In 60 days)
Pay Date Tue, Sep 3, 2019
History 26 Payments (Quarterly)

ZTS Charts

$79.28
52 Week Range
$103.75
Dec 24, 2018
May 3, 2019

101.97 48.75 34.56 0.64 ZTS NYSE -0.93 20.70 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ZTS&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ZTS&exchange=NYSE&chart=1

Shire PLC (ADR) [SHPG]
$179.20 0.00 (0.00%)

SHPG Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 33.15 Billion
SHPG Description

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.


Visit Website

SHPG Earnings

EPS 1.77 P/E Ratio 11.36
Previous Earnings --
Latest Earnings Thu, Nov 1, 2018 (199 days ago)

SHPG Dividend

Yield 0.19% / $0.34
Ex-Date Thu, Sep 6, 2018 (255 days ago)
Pay Date Fri, Oct 19, 2018
History 5 Payments (Biannual)

SHPG Charts

$156.98
52 Week Range
$181.95
Jun 19, 2018
Nov 12, 2018

179.20 33.15 11.36 0.19 SHPG NASDAQ 0.00 3.76 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SHPG&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SHPG&exchange=NASDAQ&chart=1

Cooper Companies Inc [COO]
$292.73 1.07 (0.37%)

COO Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 14.57 Billion
COO Description

Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for over 75% of total sales, CooperVision is one of the world's top four developers and manufacturers of contact lenses. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.


Visit Website

COO Earnings

EPS 2.09 P/E Ratio 102.76
Previous Earnings Tue, Mar 5, 2019
Latest Earnings Thu, May 30, 2019 (In 11 days)

COO Dividend

Yield 0.02% / $0.06
Ex-Date Fri, Jan 18, 2019 (121 days ago)
Pay Date Fri, Feb 8, 2019
History 54 Payments (Quarterly)

COO Charts

$221.97
52 Week Range
$297.59
Jun 11, 2018
Apr 2, 2019

292.73 14.57 102.76 0.02 COO NYSE 0.37 16.80 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=COO&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=COO&exchange=NYSE&chart=1

Align Technology, Inc [ALGN]
$322.61 8.26 (2.50%)

ALGN Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 26.52 Billion
ALGN Description

Align Technology provides a clear aligner therapy system, intra-oral scanners, and computer-aided design/computer-aided manufacture digital services used in dentistry and orthodontics.


Visit Website

ALGN Earnings

EPS 0.90 P/E Ratio 57.21
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Wed, Apr 24, 2019 (25 days ago)

ALGN Dividend

Yield --
Ex-Date --
Pay Date --
History --

ALGN Charts

$184.78
52 Week Range
$392.98
Jan 3, 2019
Sep 25, 2018

322.61 26.52 57.21 0.00 ALGN NASDAQ -2.50 59.61 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ALGN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ALGN&exchange=NASDAQ&chart=1

IQVIA Holdings Inc. [IQV]
$133.67 1.57 (1.16%)

IQV Profile

Sector Health Care
Industry Health Care Facilities & Services
Market Cap 26.67 Billion
IQV Description

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The CRO segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The legacy IMS business provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers.


Visit Website

IQV Earnings

EPS 0.29 P/E Ratio 107.27
Previous Earnings Thu, Feb 14, 2019
Latest Earnings Wed, May 1, 2019 (18 days ago)

IQV Dividend

Yield --
Ex-Date --
Pay Date --
History --

IQV Charts

$98.70
52 Week Range
$144.81
Jun 27, 2018
Apr 10, 2019

133.67 26.67 107.27 0.00 IQV NYSE -1.16 16.94 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IQV&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IQV&exchange=NYSE&chart=1

ResMed [RMD]
$112.78 0.65 (0.57%)

RMD Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 16.39 Billion
RMD Description

ResMed develops, manufactures, and distributes medical devices--such as airflow generators and masks--to treat breathing disorders. It also markets ventilation products, but sleep apnoea remains the company's primary focus. ResMed's reach is truly global, with distribution capabilities in more than 70 countries through wholly owned and independent firms. An increasing proportion of manufacturing capacity is in Singapore, with some still in Australia, where the company was founded.


Visit Website

RMD Earnings

EPS 0.74 P/E Ratio 31.80
Previous Earnings Thu, Jan 24, 2019
Latest Earnings Thu, May 2, 2019 (17 days ago)

RMD Dividend

Yield 1.31% / $1.48
Ex-Date Wed, May 8, 2019 (11 days ago)
Pay Date Thu, Jun 13, 2019
History 28 Payments (Quarterly)

RMD Charts

$91.56
52 Week Range
$117.84
Jan 28, 2019
Jan 18, 2019

112.78 16.39 31.80 1.31 RMD NYSE -0.57 0.90 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RMD&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RMD&exchange=NYSE&chart=1

Abiomed, Inc [ABMD]
$260.48 1.66 (0.63%)

ABMD Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 11.83 Billion
ABMD Description

Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are primarily used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. They work by improving blood flow to coronary arteries or temporarily performing the pumping function of the heart. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.


Visit Website

ABMD Earnings

EPS 1.64 P/E Ratio 54.25
Previous Earnings Thu, Jan 31, 2019
Latest Earnings Thu, May 2, 2019 (17 days ago)

ABMD Dividend

Yield --
Ex-Date --
Pay Date --
History --

ABMD Charts

$251.49
52 Week Range
$449.75
Apr 17, 2019
Sep 28, 2018

260.48 11.83 54.25 0.00 ABMD NASDAQ -0.63 -15.96 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABMD&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABMD&exchange=NASDAQ&chart=1

Nektar Therapeutics [NKTR]
$32.02 0.68 (2.17%)

NKTR Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 5.39 Billion
NKTR Description

Nektar Therapeutics is a San Francisco-based emerging biotechnology company specializing in PEGylation technology. Its portfolio includes PEGylated biologics in immuno-oncology, chronic pain, hemophilia, breast cancer, and autoimmune disease. The company partners with several large pharmaceutical and biotechnology companies to co-develop therapies in a range of indications, which includes a collaboration with Bristol-Myers Squibb to develop NKTR-214, the firm's leading immuno-oncology candidate, in combination with Bristol's Opdivo.


Visit Website

NKTR Earnings

EPS -0.68 P/E Ratio 8.20
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Wed, May 8, 2019 (11 days ago)

NKTR Dividend

Yield --
Ex-Date --
Pay Date --
History --

NKTR Charts

$30.43
52 Week Range
$90.35
Dec 24, 2018
Jun 1, 2018

32.02 5.39 8.20 0.00 NKTR NASDAQ 2.17 -6.43 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NKTR&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NKTR&exchange=NASDAQ&chart=1

Sanofi SA (ADR) [SNY]
$41.05 0.04 (0.10%)

SNY Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 102.29 Billion
SNY Description

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just under 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of sales.


Visit Website

SNY Earnings

EPS 0.46 P/E Ratio 21.78
Previous Earnings Fri, Apr 26, 2019
Latest Earnings Mon, Jul 29, 2019 (In 71 days)

SNY Dividend

Yield 4.24% / $1.74
Ex-Date Tue, May 7, 2019 (12 days ago)
Pay Date Fri, May 31, 2019
History 19 Payments (Annually)

SNY Charts

$37.85
52 Week Range
$45.59
May 29, 2018
Nov 9, 2018

41.05 102.29 21.78 4.24 SNY NYSE -0.10 -4.22 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SNY&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SNY&exchange=NYSE&chart=1

Teva Pharmaceutical Industries Ltd (ADR) ADR [TEVA]
$11.63 0.21 (1.84%)

TEVA Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 12.79 Billion
TEVA Description

Headquartered in Israel, Teva Pharmaceutical is one of the world's largest generic pharmaceutical manufacturers. The company also develops and sells branded pharmaceuticals in central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about 55% of total revenue, with branded drug and distribution revenue making up the balance of sales. Prior to generic competition, Copaxone made up about half of Teva's branded drug segment, with about $4 billion in annual sales.


Visit Website

TEVA Earnings

EPS -0.10 P/E Ratio 0.00
Previous Earnings Wed, Feb 13, 2019
Latest Earnings Thu, May 2, 2019 (17 days ago)

TEVA Dividend

Yield --
Ex-Date --
Pay Date --
History 132 Payments (Quarterly)

TEVA Charts

$11.42
52 Week Range
$25.65
May 16, 2019
Aug 20, 2018

11.63 12.79 0.00 0.00 TEVA NYSE 1.84 -26.62 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TEVA&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TEVA&exchange=NYSE&chart=1

AAC Holdings Inc [AAC]
$1.45 0.24 (14.20%)

AAC Profile

Sector Health Care
Industry Health Care Providers
Market Cap 40 Million
AAC Description

AAC Holdings Inc provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues. The company also provides drug testing, diagnostic laboratory services and provides physician services to clients. Its facilities are located throughout the United States, including residential substance abuse treatment facilities, standalone outpatient centers and sober living facilities, that focus on delivering effective clinical care and treatment solutions.


Visit Website

AAC Earnings

EPS -1.51 P/E Ratio 0.00
Previous Earnings Wed, Mar 13, 2019
Latest Earnings Thu, May 9, 2019 (10 days ago)

AAC Dividend

Yield --
Ex-Date --
Pay Date --
History --

AAC Charts

$1.40
52 Week Range
$12.33
Dec 31, 2018
May 21, 2018

1.45 0.04 0.00 0.00 AAC NYSE -14.20 -11.04 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AAC&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AAC&exchange=NYSE&chart=1

Abeona Therapeutics Inc [ABEO]
$7.44 0.01 (0.13%)

ABEO Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 370 Million
ABEO Description

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. The gene therapy involves the use of DNA as a potential therapy to treat a disease. The company's initial programs are focused on lysosomal storage diseases such as Mucopolysaccharidosis (MPS) IIIA and IIIB. It is also developing ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten Disease, respectively, ABO-401 for the treatment of cystic fibrosis, and ABO-5OX for the treatment of retinal diseases.


Visit Website

ABEO Earnings

EPS -0.39 P/E Ratio 0.00
Previous Earnings Mon, Mar 18, 2019
Latest Earnings Fri, May 10, 2019 (9 days ago)

ABEO Dividend

Yield --
Ex-Date --
Pay Date --
History --

ABEO Charts

$6.38
52 Week Range
$18.88
Feb 21, 2019
May 18, 2018

7.44 0.37 0.00 0.00 ABEO NASDAQ -0.13 5.83 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABEO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABEO&exchange=NASDAQ&chart=1

ARCA biopharma Inc [ABIO]
$9.41 0.11 (1.18%)

ABIO Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 20 Million
ABIO Description

ARCA biopharma Inc is a biopharmaceutical company. It applies precision medicine approach to develop genetically targeted therapies for cardiovascular diseases. The firm's lead product candidate is Gencaro. The company adopts genotype-directed comparative effectiveness trial of Bucindolol and Toprol-XL for prevention of symptomatic atrial fibrillation in patients with heart failure. It establishes long-term relationships with partners such as Medtronic, Laboratory Corporation of America and the University of Colorado.


Visit Website

ABIO Earnings

EPS -1.86 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

ABIO Dividend

Yield --
Ex-Date --
Pay Date --
History --

ABIO Charts

$5.04
52 Week Range
$18.36
Dec 27, 2018
Oct 1, 2018

9.41 0.02 0.00 0.00 ABIO NASDAQ 1.18 58.42 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABIO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABIO&exchange=NASDAQ&chart=1

Arbutus Biopharma Corp [ABUS]
$2.40 0.06 (2.44%)

ABUS Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 140 Million
ABUS Description

Arbutus Biopharma Corp is a pharmaceutical company. It discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.


Visit Website

ABUS Earnings

EPS -0.47 P/E Ratio 0.00
Previous Earnings Thu, Mar 7, 2019
Latest Earnings Mon, May 6, 2019 (13 days ago)

ABUS Dividend

Yield --
Ex-Date --
Pay Date --
History --

ABUS Charts

$2.20
52 Week Range
$12.35
May 13, 2019
Aug 2, 2018

2.40 0.14 0.00 0.00 ABUS NASDAQ -2.44 -40.00 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABUS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABUS&exchange=NASDAQ&chart=1

ACADIA Pharmaceuticals Inc [ACAD]
$25.03 0.63 (2.46%)

ACAD Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 3.61 Billion
ACAD Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.


Visit Website

ACAD Earnings

EPS -0.59 P/E Ratio 0.00
Previous Earnings Tue, Feb 26, 2019
Latest Earnings Wed, May 1, 2019 (18 days ago)

ACAD Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACAD Charts

$13.03
52 Week Range
$28.12
Aug 17, 2018
Apr 5, 2019

25.03 3.61 0.00 0.00 ACAD NASDAQ -2.46 50.33 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACAD&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACAD&exchange=NASDAQ&chart=1

Aurora Cannabis Inc. Common Shares [ACB]
$8.68 0.21 (2.36%)

ACB Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 8.79 Billion
ACB Description

Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis, and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities which integrate technologies across all processes are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year as well as sales and operations in 24 countries worldwide.


Visit Website

ACB Earnings

EPS -0.25 P/E Ratio 31.99
Previous Earnings Mon, Feb 11, 2019
Latest Earnings Tue, May 14, 2019 (5 days ago)

ACB Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACB Charts

$4.10
52 Week Range
$11.68
Aug 14, 2018
Oct 15, 2018

8.68 8.79 31.99 0.00 ACB NYSE -2.36 65.65 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACB&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACB&exchange=NYSE&chart=1

Acer Therapeutics Inc. - Common Stock [ACER]
$19.12 2.12 (9.98%)

ACER Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 230 Million
ACER Description

Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes two categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease.


Visit Website

ACER Earnings

EPS -0.79 P/E Ratio 0.00
Previous Earnings Thu, Mar 7, 2019
Latest Earnings Tue, May 14, 2019 (5 days ago)

ACER Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACER Charts

$16.55
52 Week Range
$32.83
Dec 24, 2018
Aug 22, 2018

19.12 0.23 0.00 0.00 ACER NASDAQ -9.98 -10.86 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACER&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACER&exchange=NASDAQ&chart=1

Aceto Corp [ACET]
$0.13 0.05 (27.78%)

ACET Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 10 Million
ACET Description

Aceto Corp is engaged in the marketing, sells and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, and specialty performance chemicals. Its business is separated into three principal segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The company derives most of its revenue from the Human Health segment.


Visit Website

ACET Earnings

EPS -0.63 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Wed, Feb 20, 2019 (88 days ago)

ACET Dividend

Yield 30.77% / $0.04
Ex-Date Fri, Sep 21, 2018 (240 days ago)
Pay Date Tue, Oct 9, 2018
History 84 Payments (Quarterly)

ACET Charts

$0.13
52 Week Range
$4.18
Apr 2, 2019
Jun 20, 2018

0.13 0.01 0.00 30.77 ACET NASDAQ -27.78 -85.23 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACET&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACET&exchange=NASDAQ&chart=1

Acadia Healthcare Co Inc [ACHC]
$32.92 0.16 (0.49%)

ACHC Profile

Sector Health Care
Industry Health Care Providers
Market Cap 2.92 Billion
ACHC Description

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.


Visit Website

ACHC Earnings

EPS 0.34 P/E Ratio 12.42
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Tue, Apr 30, 2019 (19 days ago)

ACHC Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACHC Charts

$24.75
52 Week Range
$44.94
Dec 24, 2018
Jul 26, 2018

32.92 2.92 12.42 0.00 ACHC NASDAQ 0.49 27.30 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACHC&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACHC&exchange=NASDAQ&chart=1

Achillion Pharmaceuticals Inc [ACHN]
$3.06 0.00 (0.00%)

ACHN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 420 Million
ACHN Description

Achillion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on advancing oral small molecule complement system inhibitors into late-stage development and commercialization.


Visit Website

ACHN Earnings

EPS -0.14 P/E Ratio 0.00
Previous Earnings Thu, Mar 7, 2019
Latest Earnings Thu, May 9, 2019 (10 days ago)

ACHN Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACHN Charts

$1.31
52 Week Range
$3.89
Dec 24, 2018
Oct 3, 2018

3.06 0.42 0.00 0.00 ACHN NASDAQ 0.00 81.07 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACHN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACHN&exchange=NASDAQ&chart=1

ACHIEVE LIFE SCIENCE INC [ACHV]
$3.49 0.34 (8.88%)

ACHV Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 30 Million
ACHV Description

Achieve Life Sciences Inc is a United States based clinical-stage biopharmaceutical company. It is focused on the development of novel next-generation cancer therapeutics. The company's product candidate is apatorsen which is designed to block the production of heat shock protein 27, or Hsp27, a protein that promotes treatment resistance in cancer. The group has business offices located in Bothell, Washington and Vancouver, British Columbia.


Visit Website

ACHV Earnings

EPS -0.55 P/E Ratio 0.72
Previous Earnings --
Latest Earnings --

ACHV Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACHV Charts

$1.16
52 Week Range
$11.80
Jan 14, 2019
May 21, 2018

3.49 0.03 0.72 0.00 ACHV NASDAQ -8.88 172.66 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACHV&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACHV&exchange=NASDAQ&chart=1

AC Immune SA [ACIU]
$5.09 0.06 (1.17%)

ACIU Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 350 Million
ACIU Description

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.


Visit Website

ACIU Earnings

EPS -0.21 P/E Ratio 0.00
Previous Earnings Thu, Mar 21, 2019
Latest Earnings Wed, May 15, 2019 (4 days ago)

ACIU Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACIU Charts

$3.65
52 Week Range
$16.46
Jan 30, 2019
Jul 25, 2018

5.09 0.35 0.00 0.00 ACIU NASDAQ -1.17 -50.20 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACIU&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACIU&exchange=NASDAQ&chart=1

Acorda Therapeutics Inc [ACOR]
$11.02 0.51 (4.42%)

ACOR Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 540 Million
ACOR Description

Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders.Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.


Visit Website

ACOR Earnings

EPS -1.00 P/E Ratio 0.00
Previous Earnings Thu, Feb 14, 2019
Latest Earnings Thu, May 2, 2019 (17 days ago)

ACOR Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACOR Charts

$10.05
52 Week Range
$32.60
May 1, 2019
Jun 11, 2018

11.02 0.54 0.00 0.00 ACOR NASDAQ -4.42 -32.06 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACOR&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACOR&exchange=NASDAQ&chart=1

Aclaris Therapeutics Inc [ACRS]
$5.64 0.12 (2.08%)

ACRS Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 240 Million
ACRS Description

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively.


Visit Website

ACRS Earnings

EPS -0.91 P/E Ratio 0.00
Previous Earnings Mon, Mar 18, 2019
Latest Earnings Wed, May 8, 2019 (11 days ago)

ACRS Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACRS Charts

$5.19
52 Week Range
$20.89
Apr 17, 2019
Jul 11, 2018

5.64 0.24 0.00 0.00 ACRS NASDAQ -2.08 -26.37 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACRS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACRS&exchange=NASDAQ&chart=1

AcelRx Pharmaceuticals Inc [ACRX]
$2.90 0.11 (3.94%)

ACRX Profile

Sector Health Care
Industry Medical Equipment & Devices
Market Cap 230 Million
ACRX Description

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The company's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. The company has one approved product in the U.S., DSUVIA (sufentanil sublingual tablet) known as DZUVEO in Europe indicated for the management of acute pain, severe enough to require an opioid analgesic for adult patients and one product candidate, Zalviso (sufentanil sublingual tablet system, SST system being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings.


Visit Website

ACRX Earnings

EPS -0.17 P/E Ratio 0.00
Previous Earnings Thu, Mar 7, 2019
Latest Earnings Wed, May 8, 2019 (11 days ago)

ACRX Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACRX Charts

$2.13
52 Week Range
$4.80
Dec 24, 2018
Nov 2, 2018

2.90 0.23 0.00 0.00 ACRX NASDAQ 3.94 16.94 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACRX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACRX&exchange=NASDAQ&chart=1

Acasti Pharma, Inc. - Class A Common Stock [ACST]
$0.86 0.00 (0.00%)

ACST Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 70 Million
ACST Description

Acasti Pharma Inc is a biopharmaceutical company operating in Canada. It focuses on the research, development, and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. The key product candidate of the company, CaPre is developed for the treatment of severe hypertriglyceridemia, which is a condition characterized by abnormally high levels of triglycerides in the bloodstream. The company operates through the single segment being Development and commercialization of prescription drugs.


Visit Website

ACST Earnings

EPS -0.07 P/E Ratio 0.00
Previous Earnings Wed, Nov 14, 2018
Latest Earnings Thu, Feb 14, 2019 (94 days ago)

ACST Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACST Charts

$0.45
52 Week Range
$1.57
Aug 16, 2018
Oct 1, 2018

0.86 0.07 0.00 0.00 ACST NASDAQ 0.00 -4.44 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACST&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACST&exchange=NASDAQ&chart=1

Adaptimmune Therapeutics PLC [ADAP]
$3.67 0.02 (0.54%)

ADAP Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 410 Million
ADAP Description

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types.


Visit Website

ADAP Earnings

EPS -0.24 P/E Ratio 0.00
Previous Earnings Wed, Feb 27, 2019
Latest Earnings Mon, May 6, 2019 (13 days ago)

ADAP Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADAP Charts

$3.63
52 Week Range
$14.16
Mar 22, 2019
Oct 4, 2018

3.67 0.41 0.00 0.00 ADAP NASDAQ -0.54 -33.75 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADAP&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADAP&exchange=NASDAQ&chart=1

Adial Pharmaceuticals Inc [ADIL]
$2.26 0.01 (0.44%)

ADIL Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 20 Million
ADIL Description

Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is an approved drug for treating nausea and emesis.


Visit Website

ADIL Earnings

EPS -0.33 P/E Ratio 0.00
Previous Earnings Mon, Sep 10, 2018
Latest Earnings Wed, Nov 14, 2018 (186 days ago)

ADIL Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADIL Charts

$1.21
52 Week Range
$8.33
Nov 14, 2018
Jan 15, 2019

2.26 0.02 0.00 0.00 ADIL NASDAQ 0.44 -65.23 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADIL&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADIL&exchange=NASDAQ&chart=1

ADMA Biologics Inc [ADMA]
$4.03 0.19 (4.50%)

ADMA Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 230 Million

ADMA Earnings

EPS -0.28 P/E Ratio 0.00
Previous Earnings Wed, Mar 13, 2019
Latest Earnings Wed, May 8, 2019 (11 days ago)

ADMA Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADMA Charts

$2.17
52 Week Range
$6.85
Dec 26, 2018
Sep 5, 2018

4.03 0.23 0.00 0.00 ADMA NASDAQ -4.50 53.82 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMA&exchange=NASDAQ&chart=1

Adamis Pharmaceuticals Corp [ADMP]
$1.90 0.06 (3.26%)

ADMP Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 90 Million
ADMP Description

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease and allergy. The company's Symjepi (epinephrine) Injection 0.3mg and Symjepi (epinephrine) Injection 0.15 mg products were approved for use in emergency treatment of acute allergic reactions, including anaphylaxis. It previously announced a distribution and commercialization agreement with Sandoz to market Symjepi in the US. The company is developing additional products, including a sublingual tadalafil product candidate for the treatment of erectile dysfunction, a naloxone injection product for the treatment of opioid overdose, and metered dose inhaler and dry powder inhaler product candidates.


Visit Website

ADMP Earnings

EPS -0.19 P/E Ratio 0.00
Previous Earnings Fri, Nov 9, 2018
Latest Earnings Thu, May 9, 2019 (10 days ago)

ADMP Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADMP Charts

$1.84
52 Week Range
$4.80
May 16, 2019
Jul 2, 2018

1.90 0.09 0.00 0.00 ADMP NASDAQ 3.26 -20.50 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMP&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMP&exchange=NASDAQ&chart=1

Adamas Pharmaceuticals Inc [ADMS]
$5.73 0.23 (3.86%)

ADMS Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 160 Million
ADMS Description

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.


Visit Website

ADMS Earnings

EPS -1.06 P/E Ratio 0.00
Previous Earnings Mon, Mar 4, 2019
Latest Earnings Thu, May 9, 2019 (10 days ago)

ADMS Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADMS Charts

$5.48
52 Week Range
$31.88
May 13, 2019
May 18, 2018

5.73 0.16 0.00 0.00 ADMS NASDAQ -3.86 -36.82 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMS&exchange=NASDAQ&chart=1

Aduro Biotech Inc [ADRO]
$3.13 0.06 (1.88%)

ADRO Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 260 Million
ADRO Description

Aduro Biotech Inc is a immunotherapy company focused on the discovery, development and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases. Its primary technologies related are to the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand. The STING pathway activator technology is designed to activate the intracellular STING receptor. The APRIL is a soluble factor that binds to BCMA and TACI receptors thereby inducing signaling, and is implicated in IgA nephropathy.


Visit Website

ADRO Earnings

EPS -0.29 P/E Ratio 0.00
Previous Earnings Wed, Feb 27, 2019
Latest Earnings Tue, May 7, 2019 (12 days ago)

ADRO Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADRO Charts

$2.42
52 Week Range
$8.80
Jan 28, 2019
May 31, 2018

3.13 0.26 0.00 0.00 ADRO NASDAQ -1.88 14.65 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADRO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADRO&exchange=NASDAQ&chart=1

Addus HomeCare Corp [ADUS]
$69.93 0.19 (0.27%)

ADUS Profile

Sector Health Care
Industry Health Care Providers
Market Cap 920 Million
ADUS Description

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the following segments: Personal care segment which provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.


Visit Website

ADUS Earnings

EPS 0.37 P/E Ratio 52.23
Previous Earnings Mon, Mar 4, 2019
Latest Earnings Mon, May 6, 2019 (13 days ago)

ADUS Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADUS Charts

$52.90
52 Week Range
$76.43
May 18, 2018
Dec 3, 2018

69.93 0.92 52.23 0.00 ADUS NASDAQ -0.27 7.30 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADUS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADUS&exchange=NASDAQ&chart=1

Adverum Biotechnologies Inc [ADVM]
$9.05 0.92 (11.32%)

ADVM Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 530 Million
ADVM Description

Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. The company is committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye, who currently have limited or burdensome treatment options. Its services are focused on advancing three lead gene therapy programs to address unmet needs in wet age-related macular degeneration and in rare diseases alpha-1 antitrypsin deficiency and hereditary angioedema. Its leading programs include ADVM-022, ADVM-043 and ADVM-053.


Visit Website

ADVM Earnings

EPS -0.23 P/E Ratio 0.00
Previous Earnings Wed, Mar 6, 2019
Latest Earnings Wed, May 8, 2019 (11 days ago)

ADVM Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADVM Charts

$2.87
52 Week Range
$9.05
Dec 21, 2018
May 17, 2019

9.05 0.53 0.00 0.00 ADVM NASDAQ 11.32 165.40 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADVM&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADVM&exchange=NASDAQ&chart=1

Advaxis Inc [ADXS]
$3.12 0.10 (3.31%)

ADXS Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 30 Million

ADXS Earnings

EPS 2.70 P/E Ratio 0.00
Previous Earnings Tue, Jan 15, 2019
Latest Earnings Tue, Mar 12, 2019 (68 days ago)

ADXS Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADXS Charts

$2.78
52 Week Range
$28.50
Dec 24, 2018
Jun 7, 2018

3.12 0.03 0.00 0.00 ADXS NASDAQ 3.31 -29.57 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADXS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADXS&exchange=NASDAQ&chart=1

Aerie Pharmaceuticals Inc [AERI]
$39.06 1.48 (3.65%)

AERI Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.79 Billion
AERI Description

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its main products are Rhopressa and Roclatan. The company mainly operates in North America.


Visit Website

AERI Earnings

EPS -1.06 P/E Ratio 0.00
Previous Earnings Mon, Feb 25, 2019
Latest Earnings Tue, May 7, 2019 (12 days ago)

AERI Dividend

Yield --
Ex-Date --
Pay Date --
History --

AERI Charts

$33.00
52 Week Range
$73.90
Dec 21, 2018
Jul 19, 2018

39.06 1.79 0.00 0.00 AERI NASDAQ -3.65 7.54 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AERI&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AERI&exchange=NASDAQ&chart=1

Aeterna Zentaris Inc. - Common Stock [AEZS]
$3.17 0.13 (3.94%)